Announced Tue, 22 Sept, 2026 · 22:13 IST
NCLT-convened shareholder meeting to approve Hatri Pharma merger
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+4.6%1-day move
₹15.20
prior close
₹14.95
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-4.0-4.0-7.0-7.4+4.6-1.3+1.8-1.4-2.0-4.9————
Up moveDown movePending
AI summary
NCLT Hyderabad has directed Venmax Drugs to hold an equity shareholder meeting on Saturday, October 24, 2026 at 12:30 PM via video conferencing to consider the scheme of amalgamation of Hatri Pharma Private Limited (unlisted transferor) into Venmax Drugs (listed transferee) under Sections 230-232 of the Companies Act. Remote e-voting runs from October 21 to October 23, 2026, and results are expected by October 27. The deal still requires final NCLT sanction after the shareholder vote.
Likely market impact
Shareholders will vote on the Hatri Pharma merger on Oct 24; deal needs final NCLT approval to become effective.